Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Professional Care Providers
- Remove Program Planners, Administrators, & Project Managers
- Remove Substance Abuse
- Remove Practitioner/Professional
- Remove TIP Series - Treatment Improvement Protocols (TIPS)
- Remove Evidence-Based Practices KITs
- Remove Cognitive Behavioral Therapy
- Remove Brief Intervention
- Remove Naltrexone
Main page content
Published: October 2021
This updated TIP reviews what is known about treating the medical, psychiatric, and SUD-related problems associated with the use of cocaine and methamphetamine, as well as the misuse of prescription stimulants. The TIP offers recommendations on treatment approaches and maximizing treatment engagement and retention, and strategies for initiating and maintaining abstinence.
Published: August 2021
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Published: July 2021
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Published: December 2013
This manual helps clinicians design and implement intensive outpatient treatment programs for people living with substance use disorder conditions. It discusses cultural competence and approaches, use of 12-step programs, cognitive behavioral therapy, and therapeutic communities.
Published: December 2013
This guide reviews screening tools for alcohol use and interventions for pregnant women and women of childbearing age to prevent fetal alcohol spectrum disorders (FASD). It also outlines methods for identifying people living with FASD and modifying treatment accordingly. Access the literature review.
Published: May 2013
This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.
Published: January 2013
This guide helps substance use counselors treat clients with symptoms of depression and substance use conditions. Program administrators will learn how to integrate depression treatment into early drug treatment. The guidelines cover screening, assessment, treatment, counseling, cultural competence, and continuing care.
Published: October 2012
This manual is designed as a seven-module training guide for group therapy in substance use disorder treatment. The modules assist counselors and other clinical staff in understanding and implementing evidence-based practices as described in TIP 41. Access training modules with trainers’ notes, talking points, and slides.